Life Expectancy in the United States Was About 48
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Ageing Haematopoietic Stem Cell Compartment
REVIEWS The ageing haematopoietic stem cell compartment Hartmut Geiger1,2, Gerald de Haan3 and M. Carolina Florian1 Abstract | Stem cell ageing underlies the ageing of tissues, especially those with a high cellular turnover. There is growing evidence that the ageing of the immune system is initiated at the very top of the haematopoietic hierarchy and that the ageing of haematopoietic stem cells (HSCs) directly contributes to changes in the immune system, referred to as immunosenescence. In this Review, we summarize the phenotypes of ageing HSCs and discuss how the cell-intrinsic and cell-extrinsic mechanisms of HSC ageing might promote immunosenescence. Stem cell ageing has long been considered to be irreversible. However, recent findings indicate that several molecular pathways could be targeted to rejuvenate HSCs and thus to reverse some aspects of immunosenescence. HSC niche The current demographic shift towards an ageing popu- The innate immune system is also affected by ageing. A specialized lation is an unprecedented global phenomenon that has Although an increase in the number of myeloid precur- microenvironment that profound implications. Ageing is associated with tissue sors has been described in the bone marrow of elderly interacts with haematopoietic attrition and an increased incidence of many types of can- people, the oxidative burst and the phagocytic capacity of stem cells (HSCs) to regulate cers, including both myeloid and lymphoid leukaemias, and both macrophages and neutrophils are decreased in these their fate. other haematopoietic cell malignancies1,2. Thus, we need individuals12,13. Moreover, the levels of soluble immune to understand the molecular and cellular mechanisms of mediators are altered with ageing. -
Longevity Extension from a Socioeconomic Perspective: Plausibility, Misconceptions, and Potential Outcomes
Sound Decisions: An Undergraduate Bioethics Journal Volume 2 Issue 1 Article 4 2016-12-15 Longevity Extension from a Socioeconomic Perspective: Plausibility, Misconceptions, and Potential Outcomes Eric Ralph University of Puget Sound Follow this and additional works at: https://soundideas.pugetsound.edu/sounddecisions Part of the Bioethics and Medical Ethics Commons Recommended Citation Ralph, Eric (2016) "Longevity Extension from a Socioeconomic Perspective: Plausibility, Misconceptions, and Potential Outcomes," Sound Decisions: An Undergraduate Bioethics Journal: Vol. 2 : Iss. 1 , Article 4. Available at: https://soundideas.pugetsound.edu/sounddecisions/vol2/iss1/4 This Article is brought to you for free and open access by the Student Publications at Sound Ideas. It has been accepted for inclusion in Sound Decisions: An Undergraduate Bioethics Journal by an authorized editor of Sound Ideas. For more information, please contact [email protected]. Ralph: Longevity Extension Longevity Extension from a Socioeconomic Perspective: Plausibility, Misconceptions, and Potential Outcomes Eric Ralph Introduction In the last several decades, a significant amount of progress has been made in pursuits to better understand the process of aging and subsequently gain some level of control over it. Current theories of aging are admittedly lacking, but this has not prevented biogerontologists from drastically increasing the longevity of yeast, drosophilae, worms, and mice (Vaiserman, Moskalev, & Pasyukova 2015; Tosato, Zamboni et al. 2007; Riera & Dillin 2015). Wide-ranging successes with gene therapy and increased comprehension of the genetic components of aging have also recently culminated in numerous successes in extending the longevity of animals and the first human trial of a gene therapy to extend life through telomerase manipulation is already underway, albeit on a small scale (Mendell et al. -
Worms Under Stress: Unravelling Genetic Complex Traits Through Perturbation
Worms under stress: unravelling genetic complex traits through perturbation Miriam Rodriguez Sanchez Thesis committee Promotor Prof. Dr Jaap Bakker Professor of Nematology Wageningen University Co-promotor Dr Jan E. Kammenga Associate professor, Laboratory of Nematology Wageningen University Other members Prof. Dr Bas J. Zwaan, Wageningen University Prof. Dr Hendrik.C. Korswagen, Hubrecht Institute, Utrecht Prof. Dr Ellen Nollen, European Research Institute for the Biology of Ageing (ERIBA), Groningen Dr Gino B. Poulin, University of Manchester, United Kingdom This research was conducted under the auspices of the Graduate School of Production Ecology and Resource Conservation (PE&RC). Worms under stress: unravelling genetic complex traits through perturbation Miriam Rodriguez Sanchez Thesis submitted in fulfilment of the requirements for the degree of doctor at Wageningen University by the authority of the Rector Magnificus Prof. dr. M.J. Kropff, in the presence of the Thesis Committee appointed by the Academic Board to be defended in public on Friday 14 March 2014 at 11 a.m. in the Aula. Miriam Rodriguez Sanchez Worms under stress: unravelling genetic complex traits through perturbation 130 pages PhD thesis, Wageningen University, Wageningen, NL (2014) With references, with summaries in Dutch and English ISBN: 978-94-6173-851-6 A mi padre CONTENTS Contents Chapter 1 General Introduction ........................................................................... 3 Chapter 2 C. elegans stress response and its relevance to complex human disease and aging ................................................. 15 Chapter 3 Uncovering genotype specific variation of Wnt signaling in C. elegans .................................................................... 33 Chapter 4 Genetic variation for stress-response hormesis in C. elegans life span ......................................................................... 55 Chapter 5 Molecular confirmation of trans-regulatory eQTL in C. -
"Anti-Aging Medicine" and "Successful Aging" Two Sides of the Same Coin? Views of Anti-Aging Practitioners
Flail. M.A., Seuerslen. R. A. Jr. , Ponsaran. R., & Fis hman. J.R. (20 1] ). Are ··:mt i-aging medicine'' and ··successful aging'' IWO sides of I he same coin ? Views of an ti-aging practitioners. Jmmwls or Geromolog y, Series 8: Psychological Scie11ces and Social Sciences. 68(6 ). 944--95 5. do i: 10.1093/geronb/gbt086. Ad va nce Access publicati on Septembe r 10. 20 13 Are "Anti-Aging Medicine" and "Successful Aging" Two Sides of the Same Coin? Views of Anti-Aging Practitioners Michael A. Flatt, 1 Richard A. Settersten Jr., 2 Roselle Ponsaran, 1 and Jennifer R. Fishman' 'Department of Bioethics, Case Western Reserve University, Cleveland, Ohio. 2Social and Behavioral Health Sciences, College of Public Health and Human Sciences, Oregon State University, Corvallis, Oregon. 3Biomedical Ethics Unit and the Department of the Social Studies of Medicine, McGill University, Quebec, Canada. Objectives. This article analyzes data from interviews with anti-aging practitioners to evaluate how their descriptions of the work they do, their definitions of aging, and their goals for their patients intersect with gerontological views of "successful aging." Method. Semistructured interviews were conducted with a sample of 3 I anti-aging practitioners drawn from the direc tory of the American Academy for Anti-Aging Medicine. Results. Qualitative analysis of the transcripts demonstrate that practitioners' descriptions of their goals, intentionall y or unintentionally, mimic the dominant models of "successful aging." These include lowered ri sk of disease and di sabil ity, maintenance of high levels of mental and physical function. and continuing social engagement. Yet, the means and modes of achieving·these goals differ markedly between the two groups, as do the messages that each group puts fo rth in defending their position s. -
Supercentenarians Landscape Overview
Supercentenarians Landscape Overview Top-100 Living Top-100 Longest-Lived Top-25 Socially and Professionally Active Executive and Infographic Summary GERONTOLOGY RESEARCH GROUP www.aginganalytics.com www.grg.org Supercentenarians Landscape Overview Foreword 3 Top-100 Living Supercentenarians Overview 44 Preface. How Long Can Humans Live and 4 Ages of Oldest Living Supercentenarians by Country 46 the Importance of Age Validation Top-100 Living Supercentenarians Continental Executive Summary 10 47 Distribution by Gender Introduction. 26 Top-100 Living Supercentenarians Distribution by Age 50 All Validated Supercentenarians Сhapter III. Top-25 Socially and Professionally Active All Supercentenarians Region Distribution by Gender 29 52 Living Centenarians Top-25 Socially and Professionally Active Centenarians All Supercentenarians Distribution by Nations 30 53 Overview Top-25 Socially and Professionally Active Centenarians Longest-Lived Supercentenarians Distribution by Country 31 54 Distribution by Nation Top-25 Socially and Professionally Active Centenarians All Supercentenarians Distribution by Gender and Age 32 55 Gender Distribution Top-25 Socially and Professionally Active Centenarians Сhapter I. Top-100 Longest-Lived Supercentenarians 35 56 Distribution by Type of Activity Chapter IV. Profiles of Top-100 Longest-Lived Top-100 Longest-Lived Supercentenarians Overview 36 57 Supercentenarians Top-100 Longest-Lived Supercentenarians Regional 38 Chapter V. Profiles of Top-100 Living Supercentenarians 158 Distribution by Gender Top-100 Longest-Lived Supercentenarians Distribution by Chapter VI. Profiles of Top-25 Socially and Professionally 40 259 Age Active Living Centenarians and Nonagenarians Сhapter II. Top-100 Living Supercentenarians 43 Disclaimer 285 Executive Summary There have always been human beings who have lived well beyond normal life expectancy, these ‘supercentenarians’ who lived past 110 years of age. -
Metabolic Theories of Aging
Metabolic Theories of Aging Chris Burley, Lisa K. Lashley, Charles J. Golden Nova Southeastern University Metabolic theories of aging postulate that aging is due to energy expenditure, which ultimately results in the breakdown and eventual death of cells. Historically, within the realm of metabolic theories of aging, there have been three models: The Rate-of-Living theory, The Oxidative Damage/Free Radical theory, and the Metabolic Stability theory. All three theories maintain that aging is directly related to metabolic rate, but the theories differ in how they arrive at that conclusion. The Rate-of Living theory of aging is the most antiquated of the metabolic aging theories. It proposes that two factors are responsible for determining longevity in all living organisms: 1) a genetically pre-determined capacity for overall metabolic potential, and 2) metabolic rate. The first empirical evidence for this theory dates back to 1908, when Max Rubner observed increasing metabolic rates as a function of increasing body mass in five mammalian species of varying longevities (guinea pig, cat, dog, cow, and horse). Rubner reported that the animals’ metabolic rates increased as a function of body mass, and that larger animals had longer lifespans. Based on these results, Rubner postulated that longevity could be determined by calculating the pre-determined capacity for organic energy use and the rate at which the energy was being expended. Rubner’s observation was supported by Raymond Pearl when he concluded that slower metabolism resulted in an increased lifespan among fruit flies and cantaloupe seeds. Despite the evidence for the Rate-of-Living theory, modern scientific developments have refuted the accuracy of the theory. -
World Population Ageing 2019
World Population Ageing 2019 Highlights ST/ESA/SER.A/430 Department of Economic and Social Affairs Population Division World Population Ageing 2019 Highlights United Nations New York, 2019 The Department of Economic and Social Affairs of the United Nations Secretariat is a vital interface between global policies in the economic, social and environmental spheres and national action. The Department works in three main interlinked areas: (i) it compiles, generates and analyses a wide range of economic, social and environmental data and information on which States Members of the United Nations draw to review common problems and take stock of policy options; (ii) it facilitates the negotiations of Member States in many intergovernmental bodies on joint courses of action to address ongoing or emerging global challenges; and (iii) it advises interested Governments on the ways and means of translating policy frameworks developed in United Nations conferences and summits into programmes at the country level and, through technical assistance, helps build national capacities. The Population Division of the Department of Economic and Social Affairs provides the international community with timely and accessible population data and analysis of population trends and development outcomes for all countries and areas of the world. To this end, the Division undertakes regular studies of population size and characteristics and of all three components of population change (fertility, mortality and migration). Founded in 1946, the Population Division provides substantive support on population and development issues to the United Nations General Assembly, the Economic and Social Council and the Commission on Population and Development. It also leads or participates in various interagency coordination mechanisms of the United Nations system. -
Longevity and Life Expectancy
LONGEVITY AND LIFE EXPECTANCY Cesare Marchetti International Institute for Applied Systems Analysis Laxenburg, Austria RR-97-11 September 1997 Reprinted from Technological Forecasting and Social Change, Volume 55, Number 3, July 1997. International Institute for Applied Systems Analysis, Laxenburg, Austria Tel: +43 2236 807 Fax: +43 2236 73148 E-mail: [email protected] Reseai·ch R e poi-ts , which record research conducted a.t ILA.SA , a.re independently reviewed before publication. Views or opinions expressed herein do not necessarily represent those of the Institute, its Na.tiona.l Member Orga.niza.tions, or other orga.niza.tions supporting the work. Reprinted with permission from Technological Forecasting and Social Change, Volume 55, Number 3, July 1997. Copyright @1997, Elsevier Science Inc. All rights reserved. No pa.rt. of this publica.tion ma.y be reproduced or transmitted in a.ny form or by a.ny means, electronic or mecha.nica.l, including photocopy, recording, or a.ny information storage or retrieval system, without permission in writing from the copyright holder. NORTH-HOLLAND Longevity and Life Expectancy CESARE MARCHETTI ABSTRACT The increase in life expectancy at all ages during the last two centuries is in need of a quantitative model capable of resuming the whole process under a single concept and simple mathematics. The basic hypothesis was that through improved hygiene, medicine, and life-style, the stumbling blocks to the full expression of longevity were progressively removed. The mathematics of learning processes was then applied to the secular evolution of life expectancy at various ages. The hypothesis proved very fertile. -
Addressing the Value of Gene Therapy and Enhancing Patient Access to Transformative Treatments
Position Statement Addressing the Value of Gene Therapy and Enhancing Patient Access to Transformative Treatments Rachel Salzman,1,7 Francesca Cook,2,7 Timothy Hunt,3,7 Harry L. Malech,4,7 Philip Reilly,5,7 Betsy Foss-Campbell,6 and David Barrett6 1ALD Connect, Middleton, MA, USA; 2REGENXBIO Inc., Rockville, MD, USA; 3Editas Medicine, Inc., Cambridge, MA, USA; 4Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA; 5Third Rock Ventures, Boston, MA, USA; 6American Society of Gene and Cell Therapy, Milwaukee, WI, USA; 7American Society of Gene and Cell Therapy, Value Initiative Workgroup, Milwaukee, WI, USA Although high upfront costs for the high value of gene therapy today versus paying repeatedly for treatments that may be taken at have resulted in concerns about sufficient reimbursement to regular intervals for months, years, decades, or even a lifetime. But as- allow patient access to these therapies, the significant benefits signing value to gene therapies and comparing them with potentially of gene therapies will not be realized unless patients have access lifelong illness is not an easy or straightforward task. Despite the to them. Stakeholders are discussing these issues, and the complexity, this paper identifies unique and relevant aspects that payment models being developed for the newly approved should be considered when assessing the value of gene therapy. gene therapies provide an early indication of the flexibility A related important discussion is how the costs of these treatments that will be needed from treatment manufacturers, payers, could be reduced, and whether the cost of gene therapy products and policy makers to optimize patient access. -
A Historical Perspective of Research on the Biology of Aging from Nathan W
Experimental Gerontology, Vol. 27, pp. 261-273, 1992 0531-5565/92 $5.00 + .00 Printed in the USA. All rights reserved. Copyright© 1992 Pergamon Press Ltd. Point of View A HISTORICAL PERSPECTIVE OF RESEARCH ON THE BIOLOGY OF AGING FROM NATHAN W. SHOCK GEORGE T. BAKER, liP* and W. ANDREW ACHENBAUM 2 )Shock Aging Research Foundation, 14628 Carona Drive, Silver Spring, Maryland 20905 and 21nstitute of Gerontology, University of Michigan, Ann Arbor, Michigan 48109-2007 Abstract -- This article describes some of the thoughts and the conceptual framework from which Nathan W. Shock prepared his last major presentation. This paper, written some 8 months following Dr. Shock's death on November 12, 1989, is based upon his extensive notes and discussions with one of the authors (George T. Baker). This presen- tation in no way is meant to encapsulate the long and distinguished career of Nathan Shock, but rather to provide a glimpse of his perspectives on the development of the field ofaging. Furthermore, we believe that the scientificprinciples concerning aging research laid out by Dr. Shock in this publication are still valid today and may provide valuable insights for researchers in the field. Key Words: aging research, testable hypotheses, mechanisms of aging A CRITICAL HISTORICAL ANALYSIS OF RESEARCH ON THE BIOLOGY OF AGING NATHAN W. SHOCK delivered his last major address, "Gerontology, the Study of Aging-- Past and Future," at the July 1989 Gordon Research Conference on the Biology of Aging. Four months beforehand, Shock began to review the historical development of biogeron- tology with the first author; he continued to refine his opinions until his death in Novem- ber 1989. -
Dissecting Aging and Senescence—Current Concepts and Open Lessons
cells Review Dissecting Aging and Senescence—Current Concepts and Open Lessons 1,2, , 1,2, 1 1,2 Christian Schmeer * y , Alexandra Kretz y, Diane Wengerodt , Milan Stojiljkovic and Otto W. Witte 1,2 1 Hans-Berger Department of Neurology, Jena University Hospital, 07747 Jena, Thuringia, Germany; [email protected] (A.K.); [email protected] (D.W.); [email protected] (M.S.); [email protected] (O.W.W.) 2 Jena Center for Healthy Ageing, Jena University Hospital, 07747 Jena, Thuringia, Germany * Correspondence: [email protected] These authors have contributed equally. y Received: 2 October 2019; Accepted: 13 November 2019; Published: 15 November 2019 Abstract: In contrast to the programmed nature of development, it is still a matter of debate whether aging is an adaptive and regulated process, or merely a consequence arising from a stochastic accumulation of harmful events that culminate in a global state of reduced fitness, risk for disease acquisition, and death. Similarly unanswered are the questions of whether aging is reversible and can be turned into rejuvenation as well as how aging is distinguishable from and influenced by cellular senescence. With the discovery of beneficial aspects of cellular senescence and evidence of senescence being not limited to replicative cellular states, a redefinition of our comprehension of aging and senescence appears scientifically overdue. Here, we provide a factor-based comparison of current knowledge on aging and senescence, which we converge on four suggested concepts, thereby implementing the newly emerging cellular and molecular aspects of geroconversion and amitosenescence, and the signatures of a genetic state termed genosenium. -
Mortality Improvements and Evolution of Life Expectancies
Mortality improvements and evolution of life expectancies Adrian Gallop Actuary, Pensions policy, Demography and Statistics UK Government Actuary’s Department Finlaison House 15-17 Furnival Street London EC4A 1AB United Kingdom Tel +44 20 7211 2635 e-mail: [email protected], or [email protected] 1 Mortality in the United Kingdom – 20th century trends During the course of the 20th century, the United Kingdom saw a continuation of the pattern of falling death rates that began around the beginning of the 19th century. Over these two centuries there has been a change from a regime of high infant and child mortality, with a preponderance of acute and infectious diseases, to a new regime in which adult mortality predominates and chronic and degenerative diseases are the most common causes of death. Period life expectancy at birth in the mid-19th century was around 40 years for males and 42 years for females. These figures increased to around 45 and 50 years respectively by 1901. Life expectancy then rose dramatically until the mid- 1950s. Since then, life expectancy at birth has continued to increase but at a less rapid rate (see Fig 1). Life expectancy for males rose at a lower rate than for females during the 1950s and 1960s, with the difference between males and females rising to a high of 6.3 years in 1970. Since 1970, male expectation of life has been increasing faster than female and the differential has fallen to 4.4 years by 2003. Figure 1: Period expectation of life at birth, England and Wales, 1850-2003 90 80 70 60 50 Ma l e s Expectation of life (years) of Expectation Females 40 30 1850 1860 1870 1880 1890 1900 1910 1920 1930 1940 1950 1960 1970 1980 1990 2000 Year 2 Tables 1 and 2 show how period life expectancies for England and Wales have changed over the 20th century for selected ages.